|
7:00 AM
|
8:00 AM
|
Sponsored Breakfast
|
|
|
|
|
|
8:00 AM
|
9:00 AM
|
SVM Business Meeting
|
|
|
|
|
|
9:00 AM
|
9:20 AM
|
Presidential Address Herb Aronow, MD
|
|
|
|
|
|
9:20 AM
|
10:00 AM
|
Late Breaking Science
Chaired by: Naomi Hamburg, MD and Umberto Campia, MD
|
|
|
|
|
| |
|
Evaluation of Takayasu's Arteritis Disease Activity by Ultrasound Localization Microscopy Guillaume GOUDOT, MD, PhD
|
|
|
|
|
| |
|
Natural History of Segmental Arterial Mediolysis Robert McBane, MD
|
|
|
|
|
| |
|
Identifying Genetic Variants Associated with Cerebral Atherosclerosis Using an International Classification of Diseases (ICD)-10 Based Approach in the UK Biobank Fahad Alkhalfan, MD
|
|
|
|
|
|
|
|
Randomized, Controlled Trial of a Digital Therapeutic App Providing Nutritional Cognitive Behavioral Therapy for the Treatment of Type 2 Diabetes Marc Bonaca, MD
|
|
|
|
|
|
10:00 AM
|
10:25 AM
|
Awards Presentation
|
|
|
|
|
|
10:25 AM
|
11:00 AM
|
Break
|
|
|
|
|
|
11:00 AM
|
12:00 PM
|
Carotid Artery Session
Chaired by: Daniella Kadian-Dodov, MD and Kim Smolderen, PhD
|
|
|
|
|
| |
|
Non-atherosclerotic Carotid Artery Disease: Differential Diagnosis and Evaluation: From Imaging to Testing to Care Fiorella Llanos, MD
|
|
|
|
|
| |
|
Predicting Health Status Outcomes in Carotid Disease Kim Smolderen, PhD
|
|
|
|
|
| |
|
Asymptomatic Carotid Disease - Diagnosis, Evaluation, Imaging, Tools to Decide When to Intervene Stan Henkin, MD
|
|
|
|
|
| |
|
Medical Therapy for Carotid Disease - What has been done in the trials to date and what is standard of care now? Aaron Aday, MD
|
|
|
|
|
|
|
|
Interactive Case and Panel Discussion Yulanka Castro, MD
|
|
|
|
|
|
12:00 PM
|
1:15 PM
|
Sponsored Lunch
|
|
|
|
|
|
|
|
Concurrent Sessions
|
|
1:15 PM
|
2:45 PM
|
Risk Factor Modification Session: Modern medical treatment of diabetes **NEW THIS YEAR**
Moderators: Stanislav Henkin, MD & Naomi Hamburg, MD
|
|
1:15 PM
|
2:45 PM
|
Vascular POCUS Workshop **NEW THIS YEAR**
Chaired by: Gaurav Parmar, MD and Haseeb Qazi, MD
|
| |
|
Metformin and insulin still has a role in DM, even in patients with PAD Tamar Polonksy, MD
|
|
|
|
Know your PoCUS machine and ways to incorporate in routine physical exam and bedside procedures Gaurav Parmar, MD
|
| |
|
Real world benefits of GLP-1 agonists Cecilia Low Wang, MD
|
|
|
|
PoCUS in PE evaluation- RV strain/dysfunction Haseeb Qazi, MD
|
| |
|
Avoiding SGLT2-inhibitors in PAD, an Outdated Warning? Naomi Hamburg, MD
|
|
|
|
PoCUS for vascular access Mitch Weinberg, MD
|
| |
|
Discussion
|
|
|
|
PoCUS to assess proximal LE DVT Michael Levy, MD
|
| |
|
Risk Factor Modification Session: Hyperlipidemia treatment in 2022: From statins and beyond
|
|
|
|
PoCUS to measure size of abdominal aorta and screen for AAA Billy Chacko, MD
|
| |
|
2022 Update in Statins and Statin Intolerance David Saxon, MD
|
|
|
|
|
| |
|
Here's when I consider a PCSK9i Marc Bonaca, MD
|
|
|
|
|
| |
|
Ezetemibe still has a role, despite data about PCSK9i Shireen Khoury, MD
|
|
|
|
|
| |
|
Discussion
|
|
|
|
|
| |
|
Risk Factor Modification Session: Hypertension: Update for the 2020's
|
|
|
|
|
|
|
|
Hypertension Update for the 2020’s: Case based approach to HTN management in special populations Steven Simon, MD
|
|
|
|
|
|
2:45 PM
|
3:00 PM
|
Break
|
|
|
|
|
|
3:00 PM
|
3:45 PM
|
Updates in Renal and Mesenteric Artery Disease
Moderators: Eric Secemsky & Gaurav Parmar
|
|
|
|
|
| |
|
Renal artery stenosis and HTN Anna Krawisz, MD
|
|
|
|
|
| |
|
CASE: Renal artery stenosis and HTN Ihsan Kaadan, MD
|
|
|
|
|
| |
|
Renal artery aneurysm and dissection Andrew Dicks, MD
|
|
|
|
|
| |
|
CASE: Renal artery aneurysm and dissection Siri Neelati, MD
|
|
|
|
|
| |
|
Mesenteric artery stenosis and MALS: Symptoms, imaging and management challenges Leben Tefera, MD
|
|
|
|
|
|
|
|
CASE Mesenteric artery stenosis and MALS Kunal Mishra, MD
|
|
|
|
|
|
3:45 PM
|
4:45 PM
|
SVM-AVF Joint Session
Chaired by: Eri Fukaya
|
|
|
|
|
|
|
|
Chronic Venous Thrombosis: Relief With Adjunctive Catheter-Directed Therapy - The C-TRACT Trial Suresh Vendantham, MD
|
|
|
|
|
|
|
|
When should IVC stenting be considered: what is the appropriate indication? Minhaj Khaja, MD
|
|
|
|
|
|
|
|
Venous Leg Ulcers without GSV Reflux: What do you do next? William Marston, MD
|
|
|
|
|
|
|
|
Drugs for CVD and Lymphedema: When and what to use? Eri Fukaya, MD
|
|
|
|
|
|
|
|
How to Apply Different Types of Compression: When, What, How Syed Ahsan, MD
|
|
|
|
|
|
|
|
Glycocalyx and Vascular Permeability Stanley Rockson, MD
|
|
|
|
|
|
|
|
Panel Discussion
|
|
|
|
|
|
4:45 PM
|
5:30 PM
|
Networking Happy Hour
|
|
|
|
|
|
5:30 PM
|
6:45 PM
|
Cases over Canapes
Chaired by: Ana Casanegra, MD. Moderated by: Schuyler Jones, MD and Robert McBane, MD
|
|
|
|
|
| |
|
The infrequent 'Is" of abdominal pain Andrew Dicks, MD
|
|
|
|
|
| |
|
Good things do not always come in small packages Amanda Morrison, MD
|
|
|
|
|
| |
|
When coughing up blood is a problem Christopher Caras MD
|
|
|
|
|
|
|
|
Complicated things in a 23 y/o male with a complicated condition Gayatri Suresh Kumar, MD
|
|
|
|
|